A pilot study in patients with established advanced liver fibrosis using pirfenidone

被引：72

作者：

Armendariz-Borunda, J.

Islas-Carbajal, M. C.

Meza-Garcia, E.

Rincon, A. R.

Lucano, S.

Sandoval, A. S.

Salazar, A.

Berumen, J.

Alvarez, A.

Covarrubias, A.

Arechiga, G.

Garcia, L.

机构：

[1] Univ Guadalajara, Inst Mol Biol Med & Gene Therapy, Guadalajara, Jalisco, Mexico

[2] OPD Civil Hosp Guadalajara, Guadalajara, Jalisco, Mexico

[3] Inst Chron Degenerat Dis, Guadalajara, Jalisco, Mexico

来源：

GUT | 2006年 / 55卷 / 11期

关键词：

D O I：

10.1136/gut.2006.107136

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1663 / 1665

页数：3

共 6 条

[1]

Armendariz-Borunda J, 2003, HEPATOLOGY, V38, p308A

[2] Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy [J].

Bonkovsky, HL ;

Woolley, JM .

HEPATOLOGY, 1999, 29 (01) :264-270

[3] The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen α1(I), TIMP-1 and MMP-2 [J].

Di Sario, A ;

Bendia, E ;

Macarri, G ;

Candelaresi, C ;

Taffetani, S ;

Marzioni, M ;

Omenetti, A ;

De Minicis, S ;

Trozzi, L ;

Benedetti, A .

DIGESTIVE AND LIVER DISEASE, 2004, 36 (11) :744-751

[4] Pirfenidone effectively reverses experimental liver fibrosis [J].

García, L ;

Hernández, I ;

Sandoval, A ;

Salazar, A ;

Garcia, J ;

Vera, J ;

Grijalva, G ;

Muriel, P ;

Margolin, S ;

Armendariz-Borunda, J .

JOURNAL OF HEPATOLOGY, 2002, 37 (06) :797-805

[5] Induction of collagen type I in hepatic stellate cells cocultured with Hep-G2 cells overexpressing CYP2E1. [J].

Nieto, N ;

Friedman, SL ;

Greenwel, P ;

Schuppan, D ;

Cederbaum, AI .

HEPATOLOGY, 2000, 32 (04) :185A-185A

[6] Fibrosis in chronic liver diseases: diagnosis and management [J].

Pinzani, M ;

Rombouts, K ;

Colagrande, S .

JOURNAL OF HEPATOLOGY, 2005, 42 :S22-S36

← 1 →